Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Ozempic
Ozempic
Lilly Soars After Weight-Loss Pill Results Rival Ozempic’s
Yahoo/Bloomberg
Thu, 04/17/25 - 11:34 am
Eli Lilly
clinical trials
obesity
orforglipron
Ozempic
Novo Nordisk warns consumers about counterfeit versions of Ozempic in US
Investing.com
Mon, 04/14/25 - 07:19 pm
Novo Nordisk
Ozempic
drug counterfeiting
ACC25: Ozempic shows its value in PAD
Pharmaphorum
Mon, 03/31/25 - 10:03 am
Novo Nordisk
Ozempic
type 2 diabetes
diabetes
PAD
ACC
BofA cuts Novo Nordisk shares target on expected Q1 earnings miss
Yahoo Finance
Fri, 03/28/25 - 11:22 am
Novo Nordisk
earnings
Wegovy
Ozempic
Brazil's Hypera to launch an Ozempic generic in 2026, CEO says
MSN/Reuters
Mon, 03/24/25 - 11:02 am
Hypera Pharma
semaglutide
generics
Ozempic
Novo Nordisk
Novo Nordisk welcomes patients to the Ozempic Era
Medical Marketing and Media
Mon, 03/10/25 - 09:29 am
Novo Nordisk
Ozempic
Wegovy
pharma marketing
DTC advertising
Shortage of Novo’s Wegovy and Ozempic is resolved, FDA website shows
CNBC
Fri, 02/21/25 - 10:48 am
FDA
drug shortages
Novo Nordisk
Ozempic
Wegovy
Ozempic Shows Some Promise for Alcohol Use Disorder
US News and World Report
Wed, 02/12/25 - 09:26 pm
Novo Nordisk
Ozempic
alcohol-use disorder
Wegovy and Ozempic stars dim amid overuse concerns
Axios
Tue, 02/11/25 - 11:17 am
Wegovy
Ozempic
Zepbound
Mounjaro
Novo Nordisk
Eli Lilly
GLP-1 agonists
obesity
patients
physicians
side effects
Ozempic-Like Drugs May Hold Risks For Surgical Patients, Officials Say
Forbes
Fri, 01/31/25 - 10:59 am
surgery
GLP-1 agonists
Novo Nordisk
Eli Lilly
Ozempic
Wegovy
Zepbound
Mounjaro
FDA approves new indication for Ozempic to lower kidney risks in type 2 diabetes, CKD
Healio
Tue, 01/28/25 - 09:42 pm
Novo Nordisk
FDA
Ozempic
kidney disease
Large study of Novo, Lilly weight loss drugs shows decrease in risk of Alzheimer's
Fierce Pharma
Tue, 01/21/25 - 07:13 pm
Novo Nordisk
Eli Lilly
GLP-1 agonists
Wegovy
Ozempic
Zepbound
Mounjaro
Alzheimer's disease
arthritis
Ozempic tops new Medicare price negotiation list
Pharmaphorum
Fri, 01/17/25 - 11:10 am
Novo Nordisk
Ozempic
Wegovy
Rybelsus
HHS
Inflation Reduction Act
Medicare
Use of diabetes and anti-obesity drugs surges nationwide
Axios
Fri, 01/3/25 - 10:07 am
obesity
diabetes
Eli Lilly
Novo Nordisk
Ozempic
Wegovy
Mounjaro
Zepbound
GLP-1 agonist
Novo Nordisk's Ozempic reportedly linked to vision loss in new study
Yahoo Finance
Mon, 12/16/24 - 11:39 am
Novo Nordisk
Ozempic
vision loss
Biden proposes Medicare and Medicaid cover weight loss drugs
Axios
Tue, 11/26/24 - 09:51 am
Joe Biden
Medicare
Medicaid
obesity
Novo Nordisk
Eli Lilly
Zepbound
Wegovy
Ozempic
Survey Finds Most GLP-1 Users Discontinue Drug Before Reaching Goal Weight
Xtalks
Fri, 11/15/24 - 11:27 am
Omada Health
GLP-1 agonists
obesity
weight loss
Novo Nordisk
Eli Lilly
Ozempic
Zepbound
Mounjaro
Wegovy
Compounded Ozempic tied to deaths, hospitalizations: Novo Nordisk CEO
Beckers Hospital Review
Thu, 11/7/24 - 11:14 am
Novo Nordisk
Ozempic
semaglutide
compounded drugs
FDA adds aspiration warning to Ozempic, Mounjaro and other GLP-1 labels
Beckers Hospital Review
Wed, 11/6/24 - 08:01 pm
FDA
warnings
aspiration
Ozempic
Wegovy
Saxenda
Mounjaro
Novo Nordisk
Eli Lilly
Novo takes big step toward ending Ozempic, Wegovy shortages
BioPharma Dive
Wed, 10/30/24 - 08:48 pm
Novo Nordisk
drug shortages
obesity
Ozempic
Wegovy
Pages
1
2
3
4
5
6
7
8
9
next ›
last »